RAPTIVA (efalizumab)
[back] Drug list  [back] Genentech  [back] Withdrawn drugs

[Generically known as efalizumab, Raptiva is an injectable medication used in the treatment of psoriasis. To reduce the presence of psoriasis plaques, Raptiva medication suppresses the immune system and prevents white blood cells from making their way into the skin's tissues. The Raptiva drug is produced by Genentech and Merck Serono.  Genentech recently agreed to withdraw all of the Raptiva on the U.S. market, based on the viral infections diagnosed in Raptiva patients in America and around the world.¹.]

See: Drug induced leukoencephalopathy, meningitis, viral infections

Raptiva Attorney  Despite its effectiveness at reducing psoriasis plaques, Raptiva is currently known to cause a variety of serious, potentially fatal infections, including: bacterial sepsis, invasive fungal disease, progressive multifocal leukoencephalopathy (PML), viral meningitis

Raptiva Deaths  Raptiva deaths have been reported by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency, the FDA's counterpart for the EU (European Union). The Raptiva deaths were apparently due to PML (progressive multifocal leukoencephalopathy), a devastating and rare brain infection.

External
Defective Drugs: adrugrecall.com

• Raptiva Attorney
• Death Raptiva deaths have been reported by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency, the FDA's counterpart for the EU (European Union). The Raptiva deaths were apparently due to PML (progressive multifocal leukoencephalopathy), a devastating and rare brain infection.
• Efalizumab
• Infections  Raptiva, a medication prescribed to treat Psoriasis, can cause viral infections. This is admitted by Raptiva's manufacturer, Genentech, and has been confirmed by the FDA. Indeed, the link between Raptiva and viral infections is so clear that Genentech recently agreed to withdraw all of the Raptiva on the U.S. market, based on the viral infections diagnosed in Raptiva patients in America and around the world.  Prescribed to treat psoriasis, Raptiva (efalizumab) is an injectable medication that is known to increase the risk of developing severe, life-threatening infections, including: bacterial sepsis (a blood infection), invasive fungal disease, progressive multifocal leukoencephalopathy/ PML (a type of Raptiva brain infection in which the white matter of the brain swells), viral meningitis (an infection that causes inflammation of the brain and/or spinal cord).
      While Raptiva brain infections (specifically Raptiva PML infections and meningitis) are the most deadly side effects, any of the above conditions will be fatal without emergency medical care.
• Injections
• Lawsuits
• Medication
• Prescription
• PML
• Psoriasis
• Raptiva
• Recall
• Side Effects
• Viral Infections
• Warnings